FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for fluvoxamine maleate (generic) submitted by Chartwell RX, LLC (ANDA 075900).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)